Anzeige
Mehr »
Mittwoch, 31.12.2025 - Börsentäglich über 12.000 News
Diese Batterie-Revolution könnte 2026 alles schlagen - jetzt hinschauen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
30.12.25 | 08:06
6,850 Euro
-1,44 % -0,100
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,8507,15030.12.
0,0000,00030.12.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiGrabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement250Philadelphia, Pennsylvania--(Newsfile Corp. - December 30, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) The investigation...
► Artikel lesen
MoKeyBanc maintains Sector Weight rating on Lifecore Biomedical stock1
18.12.Lifecore Biomedical, Inc.: Lifecore Biomedical to be Added to Nasdaq Biotech Index122CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced...
► Artikel lesen
17.12.Lifecore gewinnt globalen Pharmakonzern als neuen CDMO-Kunden1
17.12.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer115Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner's Program Size Positions it to Become a Top Five...
► Artikel lesen
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
17.11.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
10.11.Here's the Analysis of LifeCore's (LFCR) Growth Potential2
07.11.Lifecore outlines $74M-$76M revenue target for transition period while advancing commercial wins and margin expansion2
06.11.Lifecore Biomedical übertrifft Prognosen für Q3 2025, Aktie gibt dennoch nach1
06.11.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report-
01.11.Lifecore Biomedical: EPS übertrifft Schätzungen - Umsatz schlechter als erwartet1
31.10.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
30.10.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 20251
29.10.Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product1
29.10.Lifecore Biomedical, Inc.: Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company183Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational...
► Artikel lesen
29.10.Lifecore and PolyPeptide link for US peptide manufacturing2
28.10.Lifecore, PolyPeptide Partner on Peptide Manufacturing for U.S. Market13
28.10.Lifecore und PolyPeptide schließen Partnerschaft für integrierte Peptid-Herstellung8
28.10.Lifecore and PolyPeptide partner on integrated peptide manufacturing3
28.10.Lifecore Biomedical, Inc.; PolyPeptide Laboratories, Inc.: Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market3
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1